标普和纳斯达克内在价值 联系我们

Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Conformis, Inc. (CFMS) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 19/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
19/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
20/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
21/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — CFMS

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.26
EV/EBITDA0.0
每股数据
EPS (TTM)$-6.99
每股账面价值$0.00
每股营收$8.59
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $-277.18 $34.6M $-47.89M -138.4%
2014 $-264.64 $48.19M $-45.72M -94.9%
2015 $-65.07 $66.89M $-57.25M -85.6%
2016 $-34.67 $79.9M $-57.59M -72.1%
2017 $-30.90 $78.12M $-53.58M -68.6%
2018 $-18.41 $89.79M $-43.37M -48.3%
2019 $-11.10 $77.43M $-28.48M -36.8%
2020 $-8.47 $68.76M $-24.29M -35.3%
2021 $-0.36 $99.86M $-2.41M -2.4%
2022 $-6.99 $62.05M $-50.47M -81.3%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言